PASG
Passage Bio Inc
Price:  
0.76 
USD
Volume:  
65,222.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PASG WACC - Weighted Average Cost of Capital

The WACC of Passage Bio Inc (PASG) is 8.2%.

The Cost of Equity of Passage Bio Inc (PASG) is 12.65%.
The Cost of Debt of Passage Bio Inc (PASG) is 5.00%.

Range Selected
Cost of equity 10.70% - 14.60% 12.65%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.2% - 9.1% 8.2%
WACC

PASG WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.48 1.74
Additional risk adjustments 0.0% 0.5%
Cost of equity 10.70% 14.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 7.2% 9.1%
Selected WACC 8.2%